Core Laboratories
CLB
360 hedge funds and large institutions have $5.48B invested in Core Laboratories in 2017 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 133 increasing their positions, 124 reducing their positions, and 41 closing their positions.
47% more call options, than puts
Call options by funds: $21.1M | Put options by funds: $14.3M
2.22% more ownership
Funds ownership: 105.26% → 107.48% (+2.2%)
7% more repeat investments, than reductions
Existing positions increased: 133 | Existing positions reduced: 124
2% less capital invested
Capital invested by funds: $5.57B → $5.48B (-$85.8M)
3% less funds holding
Funds holding: 373 → 360 (-13)
12% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 41
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$181M |
| 2 |
RA
RiverPark Advisors
New York
|
+$68.9M |
| 3 |
VFA
Virtus Fund Advisers
Hartford,
Connecticut
|
+$41.4M |
| 4 |
JP Morgan Chase
New York
|
+$28.8M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$26.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$66.8M |
| 2 |
JSP
Jackson Square Partners
Larkspur,
California
|
-$43.5M |
| 3 |
Millennium Management
New York
|
-$32.8M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$22.9M |
| 5 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
-$18.7M |
CLB Hedge Fund Activity: Q1 2017 in Review
360 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q1 2017, worth a combined $5.48B — down 1.5% from $5.57B a quarter earlier.
Sellers outnumbered buyers: 41 funds closed out of CLB and 36 opened new positions — a net loss of 5 holders — while 124 trimmed existing stakes and 133 added.
The largest buyer was BlackRock, adding an estimated $181M. The largest seller was Bank of America, cutting an estimated $66.8M.
- 360 institutional investors held Core Laboratories (CLB) as of Q1 2017, down from 373 in Q4 2016.
- Funds reported $5.48B of Core Laboratories stock for Q1 2017, down 1.5% quarter-over-quarter.
- 36 funds opened new Core Laboratories positions in Q1 2017 and 41 closed out, a net change of -5 holders.
- The largest Core Laboratories buyer in Q1 2017 was BlackRock, an estimated $181M added.
- The largest Core Laboratories seller in Q1 2017 was Bank of America, an estimated $66.8M sold.
Based on aggregated 13F filings for Q1 2017.